Results 81 to 90 of about 14,254 (195)
浙江大学学报. 医学版由于缺乏有效的治疗手段，复发转移仍然是乳腺癌患者死亡的主要原因。在转移发生之前，远处器官内已经形成了适合乳腺癌细胞生长的微环境——转移前生态位（PMN）。髓源性抑制细胞（MDSC）是一类具有免疫抑制作用的异质性未成熟髓系细胞群，可在乳腺癌患者体内大量扩增，参与PMN的形成。MDSC不仅支持乳腺癌细胞免疫逃逸，而且还可通过重塑肺血管内皮细胞外基质、招募癌症干细胞来促进乳腺癌转移的发生。此外，MDSC还能通过削弱免疫疗法的抗肿瘤效率来降低药物的治疗效果。因此 ...
杜 楠楠 +4 more
doaj +1 more source
Progress in the development of mRNA vaccine and its delivery systems for anti-tumor immunotherapy [PDF]
Due to the drawbacks of low specificity and high risk of side effects of traditional anti-tumor treatments in clinical practice, novel anti-tumor immunotherapy has received attention and has been gradually applied.
XIN Meiyi, LIN Yuhong, ZHAO Kai
core +1 more source
Veterinary Dermatology, Volume 35, Issue 1, Page 5-14, February 2024.Background – Canine atopic dermatitis (AD) is a complex inflammatory skin disease associated with cutaneous microbiome, immunological and skin barrier alterations. This review summarises the current evidence on skin barrier defects and on cutaneous microbiome dysfunction in canine AD.
Domenico Santoro +13 more
wiley +1 more source
Zhongshan Daxue xuebao. Yixue kexue ban, 2000 肿瘤的免疫治疗是治疗肿瘤的新方法,它通过增强肿瘤抗原或肿瘤相关抗原的免疫原性, 诱导机体产生肿瘤特 异性的免疫应答反应而杀伤肿瘤细胞。本系列研究采用同源重组方法构建了表达人癌胚抗原( carcino embryonic antigen, CEA)的重组痘苗病毒, 经动物实验证明了其具有强免疫原性、安全性和防治 CEA 阳性肿瘤的可靠性。
罗超权 +5 more
doaj
Current status and future prospects of clinical trials for radioiodine-refractory thyroid cancer [PDF]
Radioiodine-refractory thyroid cancer (RAIR-TC) refers to thyroid cancer that is unable to or difficult to benefit from 131I treatment. The type of RAIR-TC we commonly encounter is differentiated thyroid cancer (DTC), which is originally well ...
LI Ruping, YANG Hui
core +1 more source
Strategy of Targeted T Cell Immunotherapy for Acute Myeloid Leukemia [PDF]
T cell dysfunction is a common feature in patients with acute myeloid leukemia (AML). The up-regulation of immune checkpoint (IC) proteins resulting in T cell exhaustion is a key reason for T cell dysfunction.
LI Yangqiu
core +1 more source
特异性免疫治疗对变应性鼻炎外周血ＣＤ４＋ ＣＤ２５＋Ｔ调节细胞的影响及远期疗效的观察
Zhongshan Daxue xuebao. Yixue kexue ban, 2013 【目的】 通过检测变应性鼻炎患者皮下特异性免疫治疗前后外周血ＣＤ４＋Ｔ淋巴细胞表面ＣＤ２５表达情况的变化及观察相关指标，探讨皮下特异性免疫治疗的机制，评价其远期疗效。【方法】 将９０例确诊变应性鼻炎患者随机分为免疫治疗组和药物治疗组，每组４５例。通过症状评分、使用药物评分和鼻结膜炎相关生活质量调查问卷等评价临床疗效，同时通过流式细胞仪检测外周血ＣＤ４＋Ｔ淋巴细胞表面ＣＤ２５表达情况。【结果】 随着特异性免疫治疗的进行，免疫治疗组与药物治疗组症状评分无统计学差异；而免疫治疗组药物评分要明显低于药物治疗组 ...
doaj
, 2018 近年来,随着肝细胞癌基础研究不断深入,分子靶向药物及免疫治疗药物的临床开发及应用为肝细胞癌的治疗带来了新的突破。肝细胞癌的靶向治疗药物具有较高的特异性,能够选择性地杀伤肿瘤细胞,尽可能减少对正常组织的损伤。目前,这些靶向治疗药物主要分为小分子靶向药物、肝细胞癌抗原特异性靶向药物和免疫检验点靶向药物3类 ...
邱盛萍, 黄承浩
core +1 more source
Linchuang shenzangbing zazhi, 2016 狼疮性肾炎(lupus nephritis,LN)是系统性红斑狼疮(systemic lupus erythematosus,SLE)累及肾脏的常见且严重的并发症之一,若治疗不当,最终会进展为终末期肾脏疾病,需行肾脏替代治疗。因此,早期发现、早期诊断LN,并积极进行药物干预,从而延缓其进展是治疗的关键。LN的治疗包括药物治疗、非药物治疗,前者包括糖皮质激素(glucocorticoids,GC)、免疫抑制剂、生物制剂和中药治疗,后者包括手术、肾脏替代治疗 ...
娄美玉, 陈文莉
doaj
Immunotherapy for Advanced Non-small Cell Lung Cancer: Research Progress and Perspectives [PDF]
Immunotherapy has changed the treatment landscape of advanced non-small cell lung cancer (NSCLC), showing great potential in the treatment of untreated and relapsed or refractory (R/R) patients.
Jingyi WANG, Lin WU, Yuling ZHONG
core +1 more source